Related Experiment Video
Updated: Jan 24, 2026

Demonstration of a Hyperlens-integrated Microscope and Super-resolution Imaging
Published on: September 8, 2017
Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
Jiarong Bao1,2, Man Li1, Shumei Liang1
1Department of Pathology, Zhujiang Hospital, Southern Medical University, 253 Gongye Road, Guangzhou, 510282, People's Republic of China.
Background:
Chemoresistance is a primary clinical challenge for the management of small cell lung cancer. Additionally, transcriptional regulation by super enhancer (SE) has an important role in tumor evolution. The functions of SEs, a key class of noncoding DNA cis-regulatory elements, have been the subject of many recent studies in the field of cancer research.
Methods:
In this study, using chromatin immunoprecipitation-sequencing and RNA-sequencing (RNA-seq), we aimed to identify SEs associated with chemoresistance from H69AR cells. Through integrated bioinformatics analysis of the MEME chip, we predicted the master transcriptional factors (TFs) binding to SE sites and verified the relationships between TFs of SEs and drug resistance by RNA interference, cell counting kit 8 assays, quantitative real-time reverse transcription polymerase chain reaction.
Results:
In total, 108 SEs were screened from H69AR cells. When combining this analysis with RNA-seq data, 45 SEs were suggested to be closely related to drug resistance. Then, 12 master TFs were predicted to localize to regions of those SEs. Subsequently, we selected forkhead box P1 (FOXP1), interferon regulatory factor 1 (IRF1), and specificity protein 1 (SP1) to authenticate the functional relationships of master TFs with chemoresistance via SEs.
Conclusions:
We screened out SEs involved with drug resistance and evaluated the functions of FOXP1, IRF1, and SP1 in chemoresistance. Our findings established a large group of SEs associated with drug resistance in small cell lung cancer, revealed the drug resistance mechanisms of SEs, and provided insights into the clinical applications of SEs.
Insights
Super enhancers (SEs) drive chemoresistance in small cell lung cancer. Researchers identified 45 SEs and 12 master transcription factors (TFs) linked to drug resistance, offering new therapeutic targets.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Chemoresistance presents a significant clinical hurdle in treating small cell lung cancer.
- Super enhancers (SEs), crucial noncoding DNA regulatory elements, play a vital role in tumor evolution and drug resistance.
- Understanding SE function is critical for advancing cancer therapy.
Purpose of the Study:
- To identify super enhancers (SEs) associated with chemoresistance in small cell lung cancer.
- To predict master transcription factors (TFs) regulating these SEs.
- To elucidate the functional role of SEs and their associated TFs in drug resistance.
Main Methods:
- Chromatin immunoprecipitation-sequencing (ChIP-seq) and RNA-sequencing (RNA-seq) were employed to identify SEs.
- Integrated bioinformatics analysis, including MEME chip, predicted master TFs binding to SE sites.
- Functional validation involved RNA interference, cell counting kit 8 assays, and quantitative real-time reverse transcription polymerase chain reaction.
Main Results:
- 108 SEs were identified in H69AR cells, with 45 linked to drug resistance.
- 12 master TFs were predicted to be located in SE regions associated with chemoresistance.
- Forkhead box P1 (FOXP1), interferon regulatory factor 1 (IRF1), and specificity protein 1 (SP1) were validated for their roles in chemoresistance via SEs.
Conclusions:
- This study identified a significant number of SEs involved in small cell lung cancer drug resistance.
- The findings reveal mechanisms by which SEs contribute to chemoresistance.
- The research provides potential insights for the clinical application of SEs in cancer treatment.
Related Concept Videos
Self-Evaluation: Self-Enhancement and Self-Verification
Super-resolution Fluorescence Microscopy
The Integrated Rate Law: The Dependence of Concentration on Time
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

